ARTICLE | Clinical News
Taxoprexin DHA-paclitaxel: Began Phase II trial
November 5, 2001 8:00 AM UTC
Protarga Inc., King of Prussia, Penn. Product: Taxoprexin DHA-paclitaxel Business: Cancer Therapeutic category: Cytotoxic Target: Microtubules Description: Paclitaxel linked to docosahexaenoic acid (...